Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Cell migration inhibitors from Teijin

Feb. 6, 1997

Nortran completes trials in volunteers with antiarrhythmic

Feb. 5, 1997

Tanabe synthesizes ET antagonists

Feb. 5, 1997

AHP claims smooth muscle cell proliferation inhibitors

Feb. 4, 1997

Mylan Laboratories receives FDA approval for generic formulation

Jan. 30, 1997

FDA Cardiovascular and Renal Drugs Advisory Committee to meet February 27-28

Jan. 29, 1997

New use for established antianginal agent

Jan. 29, 1997

Korean investigators isolate natural antioxidant

Jan. 28, 1997

Novel myocardial protectant described by Taiwanese researchers

Jan. 28, 1997

New approach to arrhythmia using novel SKB compound

Jan. 27, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...